pindolol has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallek, M | 1 |
| Kamp, T | 1 |
| Haen, E | 1 |
| Göhly, U | 1 |
| Emmerich, B | 1 |
| Remien, J | 1 |
1 other study available for pindolol and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Reduced responsiveness of adenylate cyclase to forskolin in human lymphoma cells.
Topics: Adenylyl Cyclase Inhibitors; Aged; B-Lymphocytes; Binding Sites; Cholera Toxin; Colforsin; Cyclic AM | 1991 |